Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events - Eikelboom, John W.; Hirsh, Jack; Weitz, Jeffrey I.; Johnston, Marilyn; Yi, Qilong; Yusuf, Salim (Circulation (New York, N.Y.), 2002)
Keywords: Aged; Angiotensin-Converting Enzyme Inhibitors - therapeutic use; Aspirin - therapeutic use; Biological and medical sciences; Blood. Blood coagulation. Reticuloendothelial system; Canada - epidemiology; Cardiovascular Diseases - drug therapy; Cardiovascular Diseases - epidemiology; Cardiovascular Diseases - metabolism; Case-Control Studies; Cohort Studies; Comorbidity; Cyclooxygenase Inhibitors - therapeutic use; Death, Sudden, Cardiac - epidemiology; Death, Sudden, Cardiac - prevention & control; Demography; Female; Follow-Up Studies; Humans; Male; Medical sciences; Myocardial Infarction - epidemiology; Myocardial Infarction - prevention & control; Odds Ratio; Pharmacology. Drug treatments; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Secondary Prevention; Stroke - epidemiology; Stroke - prevention & control; Thromboxane B2 - analogs & derivatives; Thromboxane B2 - urine; Thromboxanes - biosynthesis; Thromboxanes - urine; Vitamin E - therapeutic use; Canada; Human; Nervous system diseases; Stroke; Treatment resistance; Prognosis; Infarct; Arachidonic acid derivatives; Cardiovascular disease; Acetylsalicylic acid; Coronary heart disease; Myocardial disease; Antiplatelet agent; Cerebral disorder; Vascular disease; Chemotherapy; Treatment; Central nervous system disease; Myocardium; Salicylates; Thromboxane; Cerebrovascular disease